AVH 8.00% $2.70 avita medical inc.

Vivostat® and ReCell 'run off', page-5

  1. 223 Posts.
    lightbulb Created with Sketch. 8
    If this product is so good why isn't it selling? Is it because when sprayed on it just runs off? Does our product need a binding agent? What is our sales and marketing team for? This product is not selling! Why? Have a decent look in PubMed there is many more than 1 trial!!! Vivostat is a competitor but this isn't about them it's asking what are the problems with ReCell and why isn't it being used especially in markets where it's been approved for over a decade. It's not about FDA approval as the doctors involved in the FDA trial want to continue using without full FDA PMA approval. So IF doctors on the east coast of Australia/Europe/China/Korea/Tiawan/Middle east are aware of this why aren't they using it? Are they aware of it? Hence we come back to the poor reputation of this companies sales and marketing team which is consistently costing 3-4 times the revenue they generate!!!
 
watchlist Created with Sketch. Add AVH (ASX) to my watchlist
(20min delay)
Last
$2.70
Change
0.200(8.00%)
Mkt cap ! $187.0M
Open High Low Value Volume
$2.51 $2.81 $2.51 $2.547M 942.1K

Buyers (Bids)

No. Vol. Price($)
1 36 $2.69
 

Sellers (Offers)

Price($) Vol. No.
$2.75 100 1
View Market Depth
Last trade - 16.10pm 09/08/2024 (20 minute delay) ?
AVH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.